Clinical Trial Update: Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women [Phase 4]

View source ↗

Summary

Phase 4 trial update on vaginal estrogen for preventing recurrent urinary tract infections in postmenopausal women has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Tract Infection

Drugs mentioned

• Vaginal estrogen

Snippet

Sponsor: University of California, San Diego | Conditions: Recurrent Urinary Tract Infection | Phase 4 | Status: COMPLETED | Results posted: 2020-09-21